Unmet need in CSU: Simplified diagnosis

Simplified Diagnosis of CSU

International EAACI/GA2LEN/EDF/WAO guidelines recommend that the diagnosis of CSU should include:1

  • Patient history: to identify potential causative factors and distinguishing clinical symptoms
  • Physical examination: to help determine the presence of urticaria
  • Diagnostic tests: to confirm or exclude certain uritcaria subtypes

*Patient verbatim and profile comes from hypothetical patient for illustrative purpose only

Data from ASTERIA II; two other phase III studies (ASTERIA I and GLACIAL) were also conducted to assess efficacy and safety of Xolair® in inadequately controlled CSU patients

Xolair® 300mg vs. baseline at 12 weeks; p<0.001 vs placebo. DLQI Dermatology Life Quality Index

References: 1. Zuberbier T, et al. Allergy 2014;69:868-887. 2. Maurer M, et al. N Engl J Med 2013;368:924-935.

NP4 code: GLDEIM/IGE025E/0181

Terms of use - Privacy policy - About cookies - Cookie Settings - This site is intended for a global audience.

© 2017 Novartis Pharma